vs
阿普塔集团（ATR）与SouthState Bank Corp（SSB）财务数据对比。点击上方公司名可切换其他公司
阿普塔集团的季度营收约是SouthState Bank Corp的1.5倍（$962.7M vs $661.7M），SouthState Bank Corp净利率更高（34.1% vs 7.7%，领先26.4%），过去两年SouthState Bank Corp的营收复合增速更高（37.4% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
SouthState Bank总部位于美国佛罗里达州温特黑文，是银行控股公司SouthState Corporation旗下的银行子公司。截至2025年5月26日，该行已在南卡罗来纳、北卡罗来纳、佐治亚、佛罗里达、阿拉巴马、弗吉尼亚、科罗拉多、得克萨斯八州设有371家营业网点，为当地客户提供各类银行金融服务。
ATR vs SSB — 直观对比
营收规模更大
ATR
是对方的1.5倍
$661.7M
净利率更高
SSB
高出26.4%
7.7%
两年增速更快
SSB
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $661.7M |
| 净利润 | $74.3M | $225.8M |
| 毛利率 | — | — |
| 营业利润率 | 11.0% | 15.1% |
| 净利率 | 7.7% | 34.1% |
| 营收同比 | 13.5% | — |
| 净利润同比 | -26.4% | 153.5% |
| 每股收益（稀释后） | $1.13 | $2.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRSSB
| Q1 26 | — | $661.7M | ||
| Q4 25 | $962.7M | $581.1M | ||
| Q3 25 | $961.1M | $599.7M | ||
| Q2 25 | $966.0M | $577.9M | ||
| Q1 25 | $887.3M | $544.5M | ||
| Q4 24 | $848.1M | $369.8M | ||
| Q3 24 | $909.3M | $351.5M | ||
| Q2 24 | $910.1M | $350.3M |
净利润ATRSSB
| Q1 26 | — | $225.8M | ||
| Q4 25 | $74.3M | $247.7M | ||
| Q3 25 | $127.9M | $246.6M | ||
| Q2 25 | $111.7M | $215.2M | ||
| Q1 25 | $78.8M | $89.1M | ||
| Q4 24 | $100.9M | $144.2M | ||
| Q3 24 | $100.0M | $143.2M | ||
| Q2 24 | $90.5M | $132.4M |
营业利润率ATRSSB
| Q1 26 | — | 15.1% | ||
| Q4 25 | 11.0% | 54.3% | ||
| Q3 25 | 14.2% | 53.6% | ||
| Q2 25 | 14.9% | 48.8% | ||
| Q1 25 | 12.8% | 22.3% | ||
| Q4 24 | 14.2% | 50.7% | ||
| Q3 24 | 15.2% | 53.1% | ||
| Q2 24 | 13.8% | 49.3% |
净利率ATRSSB
| Q1 26 | — | 34.1% | ||
| Q4 25 | 7.7% | 42.6% | ||
| Q3 25 | 13.3% | 41.1% | ||
| Q2 25 | 11.6% | 37.2% | ||
| Q1 25 | 8.9% | 16.4% | ||
| Q4 24 | 11.9% | 39.0% | ||
| Q3 24 | 11.0% | 40.7% | ||
| Q2 24 | 9.9% | 37.8% |
每股收益（稀释后）ATRSSB
| Q1 26 | — | $2.28 | ||
| Q4 25 | $1.13 | $2.47 | ||
| Q3 25 | $1.92 | $2.42 | ||
| Q2 25 | $1.67 | $2.11 | ||
| Q1 25 | $1.17 | $0.87 | ||
| Q4 24 | $1.48 | $1.88 | ||
| Q3 24 | $1.48 | $1.86 | ||
| Q2 24 | $1.34 | $1.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $2.9B |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $9.0B |
| 总资产 | $5.3B | $68.0B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRSSB
| Q1 26 | — | $2.9B | ||
| Q4 25 | $409.5M | — | ||
| Q3 25 | $264.8M | — | ||
| Q2 25 | $169.8M | — | ||
| Q1 25 | $136.8M | — | ||
| Q4 24 | $226.2M | — | ||
| Q3 24 | $327.9M | — | ||
| Q2 24 | $223.9M | — |
总债务ATRSSB
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — |
股东权益ATRSSB
| Q1 26 | — | $9.0B | ||
| Q4 25 | $2.7B | $9.1B | ||
| Q3 25 | $2.8B | $9.0B | ||
| Q2 25 | $2.7B | $8.8B | ||
| Q1 25 | $2.5B | $8.6B | ||
| Q4 24 | $2.5B | $5.9B | ||
| Q3 24 | $2.5B | $5.9B | ||
| Q2 24 | $2.4B | $5.7B |
总资产ATRSSB
| Q1 26 | — | $68.0B | ||
| Q4 25 | $5.3B | $67.2B | ||
| Q3 25 | $5.1B | $66.0B | ||
| Q2 25 | $4.9B | $65.9B | ||
| Q1 25 | $4.5B | $65.1B | ||
| Q4 24 | $4.4B | $46.4B | ||
| Q3 24 | $4.6B | $46.1B | ||
| Q2 24 | $4.5B | $45.5B |
负债/权益比ATRSSB
| Q1 26 | — | — | ||
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | — |
| 自由现金流经营现金流 - 资本支出 | $96.9M | — |
| 自由现金流率自由现金流/营收 | 10.1% | — |
| 资本支出强度资本支出/营收 | 9.0% | — |
| 现金转化率经营现金流/净利润 | 2.47× | — |
| 过去12个月自由现金流最近4个季度 | $299.6M | — |
8季度趋势，按日历期对齐
经营现金流ATRSSB
| Q1 26 | — | — | ||
| Q4 25 | $183.7M | $232.1M | ||
| Q3 25 | $177.6M | $122.4M | ||
| Q2 25 | $126.0M | $72.6M | ||
| Q1 25 | $82.7M | $-126.3M | ||
| Q4 24 | $178.2M | $354.3M | ||
| Q3 24 | $229.3M | $-246.8M | ||
| Q2 24 | $143.6M | $126.8M |
自由现金流ATRSSB
| Q1 26 | — | — | ||
| Q4 25 | $96.9M | $215.5M | ||
| Q3 25 | $114.3M | $101.7M | ||
| Q2 25 | $62.5M | $52.5M | ||
| Q1 25 | $25.9M | $-139.1M | ||
| Q4 24 | $112.2M | $340.9M | ||
| Q3 24 | $162.7M | $-254.2M | ||
| Q2 24 | $75.4M | $117.3M |
自由现金流率ATRSSB
| Q1 26 | — | — | ||
| Q4 25 | 10.1% | 37.1% | ||
| Q3 25 | 11.9% | 17.0% | ||
| Q2 25 | 6.5% | 9.1% | ||
| Q1 25 | 2.9% | -25.5% | ||
| Q4 24 | 13.2% | 92.2% | ||
| Q3 24 | 17.9% | -72.3% | ||
| Q2 24 | 8.3% | 33.5% |
资本支出强度ATRSSB
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | 2.9% | ||
| Q3 25 | 6.6% | 3.5% | ||
| Q2 25 | 6.6% | 3.5% | ||
| Q1 25 | 6.4% | 2.4% | ||
| Q4 24 | 7.8% | 3.6% | ||
| Q3 24 | 7.3% | 2.1% | ||
| Q2 24 | 7.5% | 2.7% |
现金转化率ATRSSB
| Q1 26 | — | — | ||
| Q4 25 | 2.47× | 0.94× | ||
| Q3 25 | 1.39× | 0.50× | ||
| Q2 25 | 1.13× | 0.34× | ||
| Q1 25 | 1.05× | -1.42× | ||
| Q4 24 | 1.77× | 2.46× | ||
| Q3 24 | 2.29× | -1.72× | ||
| Q2 24 | 1.59× | 0.96× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
SSB
| Net Interest Income | $561.6M | 85% |
| Noninterest Income | $100.1M | 15% |
